Cutter & CO Brokerage Inc. grew its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 29.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,296 shares of the company's stock after buying an additional 1,652 shares during the quarter. Cutter & CO Brokerage Inc.'s holdings in Cardinal Health were worth $1,005,000 at the end of the most recent quarter.
Several other institutional investors have also made changes to their positions in CAH. Cyrus J. Lawrence LLC acquired a new position in Cardinal Health during the fourth quarter valued at $26,000. Bellwether Advisors LLC acquired a new position in shares of Cardinal Health in the 4th quarter valued at about $32,000. Tompkins Financial Corp lifted its position in shares of Cardinal Health by 106.7% in the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock worth $34,000 after purchasing an additional 128 shares in the last quarter. Lee Danner & Bass Inc. purchased a new stake in shares of Cardinal Health in the fourth quarter worth approximately $35,000. Finally, Itau Unibanco Holding S.A. acquired a new stake in shares of Cardinal Health during the fourth quarter worth approximately $36,000. 87.17% of the stock is owned by hedge funds and other institutional investors.
Cardinal Health Trading Down 0.8%
Shares of Cardinal Health stock opened at $160.87 on Monday. The stock has a market capitalization of $38.40 billion, a price-to-earnings ratio of 25.10, a PEG ratio of 1.59 and a beta of 0.68. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $168.44. The firm has a fifty day simple moving average of $157.67 and a 200-day simple moving average of $139.03.
Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.15 by $0.20. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. The company had revenue of $54.88 billion for the quarter, compared to the consensus estimate of $55.33 billion. During the same period last year, the business posted $2.08 earnings per share. The firm's revenue was up .0% compared to the same quarter last year. As a group, research analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.
Cardinal Health Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be given a dividend of $0.5107 per share. The ex-dividend date is Tuesday, July 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.27%. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's payout ratio is 31.83%.
Analyst Ratings Changes
A number of equities research analysts have issued reports on CAH shares. Wells Fargo & Company upgraded shares of Cardinal Health from an "equal weight" rating to an "overweight" rating and increased their target price for the stock from $136.00 to $179.00 in a research report on Tuesday, June 3rd. Morgan Stanley set a $181.00 price objective on Cardinal Health and gave the company an "overweight" rating in a research report on Friday, June 13th. Robert W. Baird increased their price objective on Cardinal Health from $156.00 to $170.00 and gave the stock an "outperform" rating in a report on Friday, May 2nd. Mizuho raised their price objective on shares of Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research report on Monday, March 31st. Finally, Wall Street Zen upgraded shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Monday, May 5th. Three research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Cardinal Health currently has an average rating of "Moderate Buy" and an average price target of $157.43.
Read Our Latest Report on CAH
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.